CF
TWST icon

Corebridge Financial’s Twist Bioscience TWST Stock Holding History

Corebridge Financial’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,040
Closed -$1.14M – 2614
2025
Q1 		$1.14M Buy
29,040
+62
+0.2% +$2.79K 0.01% 1209
2024
Q4 		$1.35M Sell
28,978
-1,781
-6% -$80.5K 0.01% 1192
2024
Q3 		$1.39M Sell
30,759
-189
-0.6% -$8.99K 0.01% 1206
2024
Q2 		$1.53M Buy
+30,948
New +$1.26M 0.01% 1119

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Corebridge Financial's TWST Position: Q2 2025 in Review

Corebridge Financial sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 29,040 shares — an estimated $1.14M sold.

Corebridge Financial first reported a position in TWST in Q2 2024 and held it in 4 quarters. The position peaked at $1.53M in Q2 2024. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Corebridge Financial reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 29,040 Twist Bioscience shares in Q2 2025, an estimated $1.14M.
  • Corebridge Financial first reported a position in Twist Bioscience in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Twist Bioscience position peaked at $1.53M in Q2 2024.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.